Pharmaceutical thrombosis prevention in cardiovascular disease

Author： Eriksson Mats   Christensen Kjeld   Lindahl Tomas L   Larsson Anders  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.4, 2002-04, pp. : 553-563

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid Management for the Prevention of Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 852-860

Bentham Science Publishers

Access to resources Recommend Favorite

Garlic for Cardiovascular Disease: Prevention or Treatment?

By  

Current Pharmaceutical Design, Vol. 23, Iss. 7, 2017-04 ,pp. : 1028-1041

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus

By Colwell John A.  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. : 87-106

Adis International

Access to resources Recommend Favorite

Telmisartan: A Review of its Use in Cardiovascular Disease Prevention

By Frampton James E.  

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 651-677

Adis International

Access to resources Recommend Favorite

Targeting platelets for prevention and treatment of cardiovascular disease

By Duhamel Todd A   Xu Yan-Jun   Arneja Amarjit S   Dhalla Naranjan S  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1523-1533

Informa Healthcare

Access to resources Recommend Favorite